James just mentioned something that we talk about often, partly because our programming is very oversubscribed in both our programs, WINN and WDP, but on the WINN side in particular. In the types of technologies coming forward, what we're seeing the need for patient capital. Even our WINN program has timelines—three years to commercialization—and depending upon which sectors you wanting to invest in three years is not a long time. Patient capital is very important to achieve some of those commercialization results you're talking about.
Thank you.